𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neopterin and beta-2 microglobulin levels in asymptomatic HIV infection: The predictive value of combining markers

✍ Scribed by Dr. Nigel A. Harrison; Susan J. Skidmore

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
558 KB
Volume
32
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The concentrations of neopterin, beta‐2 microglobulin, p24 antigen anti‐p24 antibody, and alpha‐interferon were determined in the sera of 25 asymptomatic anti‐HIV positive patients (CDC stages II and III) over a 50 month period (38 months retrospectively and 12 months prospectively). Evaluation of the data allowed the derivation of a threshold of abnormality for both neopterin and beta‐2 microglobulin. Pre‐AIDS (CDC groups IVa, IVc2, IVe) developed in 6 of the 26 patients within 18 months of the first abnormal value of beta‐2 microglobulin, and within 12 months of the first abnormal value of neopterin. Combining the abnormal results of neopterin, beta‐2 microglobulin, p24 antigen, and alpha‐interferon allows prediction of progression to pre‐AIDS within 18 months for most asymptomatic patients.

📜 SIMILAR VOLUMES

Predictive value of drug levels, HIV gen
Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients
✍ Luisa Valer; Carmen de Mendoza; Vincent Soriano 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Plasma levels of HIV protease inhibitors (PI) are often close to IC50 values of wild-type viruses when administered without ritonavir boosting. The impact of drug levels, resistance mutations, and the genotypic inhibitory quotient (GIQ) were examined on the response to saquinavir/ritonavir (SQV/r)-b

Evaluation of hiv p24 antigen, beta2-mic
Evaluation of hiv p24 antigen, beta2-microglobulin, neopterin, soluble cd4, soluble cd8, and soluble interleukin-2 receptor levels in patients with aids or aids-related complex treated with 2′,3′-dideoxyinosine (ddl)
✍ Mohan M. Reddy; George F. McKinley; Michael H. Grieco 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

Circulating HIV P24 antigen, beta2-microglobulin, neopterin, soluble CD4, soluble CD8, and soluble interleukin-2 receptor were measured in 13 zidovudine-intolerant patients (8 with ARC and 5 with AIDS) treated with dideoxyinosine (ddl). Measurements were made at baseline and at several intervals dur